Transcriptomics reveals in vivo efficacy of PARP inhibitor combinatorial synergy with platinum-based chemotherapy in human non-small cell lung carcinoma models
Transcriptomics reveals in vivo efficacy of PARP inhibitor combinatorial synergy with platinum-based chemotherapy in human non-small cell lung carcinoma models |
|
https://doi.org/10.18632/oncotarget.28162
Lindsay R. Stolzenburg,
Barrett Ainsworth,
Bridget Riley-Gillis,
Tibor Pakozdi,
Areej Ammar,
Paul A. Ellis,
Julie L. Wilsbacher,
and Cyril Y. Ramathal
|
| 1-12 |
Unravelling the underpinnings of hyperprogression and immunotherapy: back to the bench
Unravelling the underpinnings of hyperprogression and immunotherapy: back to the bench |
|
https://doi.org/10.18632/oncotarget.28098
Vivek Subbiah,
and Razelle Kurzrock
|
| 13-15 |
Oxygen-independent, CDK4/CDK6-dependent degradation of hypoxia-inducible factor-1α takes cancers’ breath away
Oxygen-independent, CDK4/CDK6-dependent degradation of hypoxia-inducible factor-1α takes cancers’ breath away |
|
https://doi.org/10.18632/oncotarget.28166
Len Neckers
|
| 16-17 |
The “Immunoscore” in rectal cancer: could we search quality beyond quantity of life?
The “Immunoscore” in rectal cancer: could we search quality beyond quantity of life? |
|
https://doi.org/10.18632/oncotarget.28100
Amos Kirilovsky,
Carine El Sissy,
Guy Zeitoun,
Florence Marliot,
Nacilla Haicheur,
Christine Lagorce-Pagès,
Julien Taieb,
Mehdi Karoui,
Petra Custers,
Edina Dizdarevic,
Soledad Iseas,
Torben Frøstrup Hansen,
Lars Henrik Jensen,
Geerard Beets,
Jean Pierre Gérard,
Mireia Castillo-Martin,
Nuno Figueiredo,
Angelita Habr-Gama,
Rodrigo Perez,
Jérôme Galon,
and Franck Pagès
|
| 18-31 |
Induction of serine hydroxymethyltransferase 2 promotes tumorigenesis and metastasis in neuroblastoma
Induction of serine hydroxymethyltransferase 2 promotes tumorigenesis and metastasis in neuroblastoma |
|
https://doi.org/10.18632/oncotarget.28168
Rachael A. Clark,
Jingbo Qiao,
Jillian C. Jacobson,
and Dai H. Chung
|
| 32-45 |
The androgen receptor inhibits transcription of GPER1 by preventing Sp1 and Sp3 from binding to the promoters in prostate cancer cells
The androgen receptor inhibits transcription of GPER1 by preventing Sp1 and Sp3 from binding to the promoters in prostate cancer cells |
|
https://doi.org/10.18632/oncotarget.28169
Austin McDermott,
KyoungHyun Kim,
Susan Kasper,
Shuk-Mei Ho,
and Yuet-Kin Leung
|
| 46-60 |
Early detection of treatment futility in patients with metastatic colorectal cancer
Early detection of treatment futility in patients with metastatic colorectal cancer |
|
https://doi.org/10.18632/oncotarget.28165
Jodi I. Rattner,
Karen A. Kopciuk,
Hans J. Vogel,
Patricia A. Tang,
Jeremy D. Shapiro,
Dongsheng Tu,
Derek J. Jonker,
Lillian L. Siu,
Chris J. O’Callaghan,
and Oliver F. Bathe
|
| 61-72 |
Altered glycosylation of several metastasis-associated glycoproteins with terminal GalNAc defines the highly invasive cancer cell phenotype
Altered glycosylation of several metastasis-associated glycoproteins with terminal GalNAc defines the highly invasive cancer cell phenotype |
|
https://doi.org/10.18632/oncotarget.28167
Elham Khosrowabadi,
Tomasz Wenta,
Salla Keskitalo,
Aki Manninen,
and Sakari Kellokumpu
|
| 73-89 |
Are 50 years enough to prove the brilliant Dilman’s idea?
Are 50 years enough to prove the brilliant Dilman’s idea? |
|
https://doi.org/10.18632/oncotarget.28097
Vladimir N. Anisimov
|
| 90-91 |
GZ17-6.02 and palbociclib interact to kill ER+ breast cancer cells
GZ17-6.02 and palbociclib interact to kill ER+ breast cancer cells |
|
https://doi.org/10.18632/oncotarget.28177
Laurence Booth,
Cameron West,
Robert P. Moore,
Daniel Von Hoff,
and Paul Dent
|
| 92-104 |
Exploiting protein family and protein network data to identify novel drug targets for bladder cancer
Exploiting protein family and protein network data to identify novel drug targets for bladder cancer |
|
https://doi.org/10.18632/oncotarget.28175
Tolulope Tosin Adeyelu,
Aurelio A. Moya-Garcia,
and Christine Orengo
|
| 105-117 |
Correction: Prediction of survival prognosis of non-small cell lung cancer by APE1 through regulation of epithelial-mesenchymal transition
Correction: Prediction of survival prognosis of non-small cell lung cancer by APE1 through regulation of epithelial-mesenchymal transition |
|
https://doi.org/10.18632/oncotarget.28141
Xi Wei,
Qing Li,
Ying Li,
Wei Duan,
Chongbiao Huang,
Xiangqian Zheng,
Lei Sun,
Jingtao Luo,
Dong Wang,
Sheng Zhang,
Xiaojie Xin,
and Ming Gao
|
| 118-119 |
Redefining and expanding the sphere of influence of BRCA in breast and colorectal cancers and beyond
Redefining and expanding the sphere of influence of BRCA in breast and colorectal cancers and beyond |
|
https://doi.org/10.18632/oncotarget.28164
Emil Lou
|
| 120-121 |
Suppressive GLI2 fragment enhances liver metastasis in colorectal cancer
Suppressive GLI2 fragment enhances liver metastasis in colorectal cancer |
|
https://doi.org/10.18632/oncotarget.28170
Ruiko Ogata,
Shiori Mori,
Hitoshi Ohmori,
Shingo Kishi,
Rina Fujiwara-Tani,
Takamitsu Sasaki,
Yukiko Nishiguchi,
Chie Nakashima,
Kei Goto,
Isao Kawahara,
Yi Luo,
and Hiroki Kuniyasu
|
| 122-135 |
Chimeric chromosome landscapes of human somatic cell cultures show dependence on stress and regulation of genomic repeats by CGGBP1
Chimeric chromosome landscapes of human somatic cell cultures show dependence on stress and regulation of genomic repeats by CGGBP1 |
|
https://doi.org/10.18632/oncotarget.28174
Subhamoy Datta,
Manthan Patel,
Sukesh Kashyap,
Divyesh Patel,
and Umashankar Singh
|
| 136-155 |
Synthesis of a novel nanobioconjugate for targeted photodynamic therapy of colon cancer enhanced with cannabidiol
Synthesis of a novel nanobioconjugate for targeted photodynamic therapy of colon cancer enhanced with cannabidiol |
|
https://doi.org/10.18632/oncotarget.28171
Nkune Williams Nkune,
Cherie Ann Kruger,
and Heidi Abrahamse
|
| 156-172 |
Seventh BHD international symposium: recent scientific and clinical advancement
Seventh BHD international symposium: recent scientific and clinical advancement |
|
https://doi.org/10.18632/oncotarget.28176
Mark R. Woodford,
Avgi Andreou,
Masaya Baba,
Irma van de Beek,
Chiara Di Malta,
Iris Glykofridis,
Hannah Grimes,
Elizabeth P. Henske,
Othon Iliopoulos,
Masatoshi Kurihara,
Romain Lazor,
W. Marston Linehan,
Kenki Matsumoto,
Stefan J. Marciniak,
Yukiko Namba,
Arnim Pause,
Neil Rajan,
Anindita Ray,
Laura S. Schmidt,
Wei Shi,
Ortrud K. Steinlein,
Julia Thierauf,
Roberto Zoncu,
Anna Webb,
and Mehdi Mollapour
|
| 173-181 |
Correction: Musashi2 promotes the development and progression of pancreatic cancer by down-regulating Numb protein
Correction: Musashi2 promotes the development and progression of pancreatic cancer by down-regulating Numb protein |
|
https://doi.org/10.18632/oncotarget.28157
Weiwei Sheng,
Ming Dong,
Chuanping Chen,
Yang Li,
Qingfeng Liu,
and Qi Dong
|
| 182-182 |
Influence of nutrition on stage-stratified survival in gastric cancer patients with postoperative complications
Influence of nutrition on stage-stratified survival in gastric cancer patients with postoperative complications |
|
https://doi.org/10.18632/oncotarget.28179
Noriyuki Hirahara,
Takeshi Matsubara,
Shunsuke Kaji,
Yuki Uchida,
Ryoji Hyakudomi,
Tetsu Yamamoto,
Kiyoe Takai,
Yohei Sasaki,
Koki Kawakami,
and Yoshitsugu Tajima
|
| 183-197 |
Common cancer treatments targeting DNA double strand breaks affect long-term memory and relate to immediate early gene expression in a sex-dependent manner
Common cancer treatments targeting DNA double strand breaks affect long-term memory and relate to immediate early gene expression in a sex-dependent manner |
|
https://doi.org/10.18632/oncotarget.28180
Sydney Weber Boutros,
Destine Krenik,
Sarah Holden,
Vivek K. Unni,
and Jacob Raber
|
| 198-213 |
Plasma biomarkers reflecting high oxidative stress in the prediction of myocardial injury due to anthracycline chemotherapy and the effect of carvedilol: insights from the CECCY Trial
Plasma biomarkers reflecting high oxidative stress in the prediction of myocardial injury due to anthracycline chemotherapy and the effect of carvedilol: insights from the CECCY Trial |
|
https://doi.org/10.18632/oncotarget.28182
Mauro Rogério de Barros Wanderley Jr.,
Mônica Samuel Ávila,
Miguel Morita Fernandes-Silva,
Fátima das Dores Cruz,
Sara Michelly Gonçalves Brandão,
Vagner Oliveira Carvalho Rigaud,
Ludhmila Abrahão Hajjar,
Roberto Kalil Filho,
Edécio Cunha-Neto,
Edimar Alcides Bocchi,
and Silvia Moreira Ayub-Ferreira
|
| 214-223 |
Impact of the glutathione synthesis pathway on sulfasalazine-treated endometrial cancer
Impact of the glutathione synthesis pathway on sulfasalazine-treated endometrial cancer |
|
https://doi.org/10.18632/oncotarget.28185
Kanako Sendo,
Manabu Seino,
Tsuyoshi Ohta,
and Satoru Nagase
|
| 224-236 |
Exploring the synergistic effects of cabozantinib and a programmed cell death protein 1 inhibitor in metastatic renal cell carcinoma with machine learning
Exploring the synergistic effects of cabozantinib and a programmed cell death protein 1 inhibitor in metastatic renal cell carcinoma with machine learning |
|
https://doi.org/10.18632/oncotarget.28183
Ignacio Durán,
Daniel Castellano,
Javier Puente,
Lidia Martín-Couce,
Esther Bello,
Urbano Anido,
José Manuel Mas,
and Luis Costa
|
| 237-256 |
Real-world survival analysis by tumor mutational burden in non-small cell lung cancer: a multisite U.S. study
Real-world survival analysis by tumor mutational burden in non-small cell lung cancer: a multisite U.S. study |
|
https://doi.org/10.18632/oncotarget.28178
Connor Willis,
Hillevi Bauer,
Trang H. Au,
Jyothi Menon,
Sudhir Unni,
Dao Tran,
Zachary Rivers,
Wallace Akerley,
Matthew B. Schabath,
Firas Badin,
Ashley Sekhon,
Malini Patel,
Bing Xia,
Beth Gustafson,
John L. Villano,
John-Michael Thomas,
Solomon J. Lubinga,
Michael A. Cantrell,
Diana Brixner,
and David Stenehjem
|
| 257-270 |
Correction: The attenuated hepatocellular carcinoma-specific Listeria vaccine Lmdd-MPFG prevents tumor occurrence through immune regulation of dendritic cells
Correction: The attenuated hepatocellular carcinoma-specific Listeria vaccine Lmdd-MPFG prevents tumor occurrence through immune regulation of dendritic cells |
|
https://doi.org/10.18632/oncotarget.28154
Xin Wan,
Ci Cheng,
Zhe Lin,
Runqiu Jiang,
Wei Zhao,
Xin Yan,
Junwei Tang,
Kun Yao,
Beicheng Sun,
and Yun Chen
|
| 271-272 |
Positive predictive value of ERBB2 copy number gain by tissue or circulating tumor DNA next-generation sequencing across advanced cancers
Positive predictive value of ERBB2 copy number gain by tissue or circulating tumor DNA next-generation sequencing across advanced cancers |
|
https://doi.org/10.18632/oncotarget.28188
Ami N. Shah,
Ashwin Sunderraj,
Brian Finkelman,
Sharlene H. See,
Andrew A. Davis,
Lorenzo Gerratana,
Firas Wehbe,
Neelima Katam,
Deva Mahalingam,
William J. Gradishar,
Amir Behdad,
Luis Blanco,
and Massimo Cristofanilli
|
| 273-280 |
GZ17-6.02 and axitinib interact to kill renal carcinoma cells
GZ17-6.02 and axitinib interact to kill renal carcinoma cells |
|
https://doi.org/10.18632/oncotarget.28189
Laurence Booth,
Cameron West,
Robert P. Moore,
Daniel Von Hoff,
and Paul Dent
|
| 281-290 |
PACER lncRNA regulates COX-2 expression in lung cancer cells
PACER lncRNA regulates COX-2 expression in lung cancer cells |
|
https://doi.org/10.18632/oncotarget.28190
Samuel Z. Desind,
Joseph R. Iacona,
Christina Y. Yu,
Antonina Mitrofanova,
and Carol S. Lutz
|
| 291-306 |
Antitumor effect of isoquercetin on tissue vasohibin expression and colon cancer vasculature
Antitumor effect of isoquercetin on tissue vasohibin expression and colon cancer vasculature |
|
https://doi.org/10.18632/oncotarget.28181
Daniel de Castilho da Silva,
Guilherme Di Camillo Orfali,
Maycon Giovani Santana,
Jessica Kaoru Yamamoto Palma,
Isabella Ramos de Oliveira Assunção,
Isadora Moraes Marchesi,
Ana Yoshie Kitagawa Grizotto,
Natália Peres Martinez,
Simone Felliti,
José Aires Pereira,
and Denise Gonçalves Priolli
|
| 307-318 |
ABT199/venetoclax potentiates the cytotoxicity of alkylating agents and fludarabine in acute myeloid leukemia cells
ABT199/venetoclax potentiates the cytotoxicity of alkylating agents and fludarabine in acute myeloid leukemia cells |
|
https://doi.org/10.18632/oncotarget.28193
Benigno C. Valdez,
David Murray,
Bin Yuan,
Yago Nieto,
Uday Popat,
and Borje S. Andersson
|
| 319-330 |
Correction: 2’-Hydroxyflavanone effectively targets RLIP76-mediated drug transport and regulates critical signaling networks in breast cancer
Correction: 2’-Hydroxyflavanone effectively targets RLIP76-mediated drug transport and regulates critical signaling networks in breast cancer |
|
https://doi.org/10.18632/oncotarget.28199
Lokesh Dalasanur Nagaprashantha,
Jyotsana Singhal,
Hongzhi Li,
Charles Warden,
Xueli Liu,
David Horne,
Sanjay Awasthi,
Ravi Salgia,
and Sharad S. Singhal
|
| 331-331 |
Etoposide-induced DNA damage is increased in p53 mutants: identification of ATR and other genes that influence effects of p53 mutations on Top2-induced cytotoxicity
Etoposide-induced DNA damage is increased in p53 mutants: identification of ATR and other genes that influence effects of p53 mutations on Top2-induced cytotoxicity |
|
https://doi.org/10.18632/oncotarget.28195
Daniel Menendez,
Jay R. Anand,
Carri C. Murphy,
Whitney J. Bell,
Jiaqi Fu,
Nadia Slepushkina,
Eugen Buehler,
Scott E. Martin,
Madhu Lal-Nag,
John L. Nitiss,
and Michael A. Resnick
|
| 332-346 |
Telomere shortening accelerates tumor initiation in the L2-IL1B mouse model of Barrett esophagus and emerges as a possible biomarker
Telomere shortening accelerates tumor initiation in the L2-IL1B mouse model of Barrett esophagus and emerges as a possible biomarker |
|
https://doi.org/10.18632/oncotarget.28198
Vincenz Sahm,
Carlo Maurer,
Theresa Baumeister,
Akanksha Anand,
Julia Strangmann,
Roland M. Schmid,
Timothy C. Wang,
and Michael Quante
|
| 347-359 |
A comparison of 64Cu-labeled bi-terminally PEGylated A20FMDV2 peptides targeting integrin ανβ6
A comparison of 64Cu-labeled bi-terminally PEGylated A20FMDV2 peptides targeting integrin ανβ6 |
|
https://doi.org/10.18632/oncotarget.28197
Truc T. Huynh,
Sreeja Sreekumar,
Cedric Mpoy,
and Buck E. Rogers
|
| 360-372 |
NOTCH1 PEST domain variants are responsive to standard of care treatments despite distinct transformative properties in a breast cancer model
NOTCH1 PEST domain variants are responsive to standard of care treatments despite distinct transformative properties in a breast cancer model |
|
https://doi.org/10.18632/oncotarget.28200
Karen Cravero,
Morgan V. Pantone,
Dong Ho Shin,
Riley Bergman,
Rory Cochran,
David Chu,
Daniel J. Zabransky,
Swathi Karthikeyan,
Ian G. Waters,
Natasha Hunter,
D. Marc Rosen,
Kelly Kyker-Snowman,
W. Brian Dalton,
Berry Button,
Dan Shinn,
Hong Yuen Wong,
Joshua Donaldson,
Paula J. Hurley,
Sarah Croessmann,
and Ben Ho Park
|
| 373-386 |
Metanephric adenoma: molecular study and review of the literature
Metanephric adenoma: molecular study and review of the literature |
|
https://doi.org/10.18632/oncotarget.28192
Enrique Rodríguez-Zarco,
Jesús Machuca-Aguado,
Laura Macías-García,
Ana Vallejo-Benítez,
and Juan José Ríos-Martín
|
| 387-392 |
The role of IGF-pathway biomarkers in determining risks, screening, and prognosis in lung cancer
The role of IGF-pathway biomarkers in determining risks, screening, and prognosis in lung cancer |
|
https://doi.org/10.18632/oncotarget.28202
Alexander W. Pohlman,
Hita Moudgalya,
Lia Jordano,
Gabriela C. Lobato,
David Gerard,
Michael J. Liptay,
Christopher W. Seder,
and Jeffrey A. Borgia
|
| 393-407 |
The long winding road to the safer glucocorticoid receptor (GR) targeting therapies
The long winding road to the safer glucocorticoid receptor (GR) targeting therapies |
|
https://doi.org/10.18632/oncotarget.28191
Ekaterina A. Lesovaya,
Daria Chudakova,
Gleb Baida,
Ekaterina M. Zhidkova,
Kirill I. Kirsanov,
Marianna G. Yakubovskaya,
and Irina V. Budunova
|
| 408-424 |
Correction: IL-17A weakens the antitumor immunity by inhibiting apoptosis of MDSCs in Lewis lung carcinoma bearing mice
Correction: IL-17A weakens the antitumor immunity by inhibiting apoptosis of MDSCs in Lewis lung carcinoma bearing mice |
|
https://doi.org/10.18632/oncotarget.28052
Juan Wang,
Yue Zhang,
Kai Yin,
Peiqi Xu,
Jie Tian,
Jie Ma,
Xinyu Tian,
Yungang Wang,
Xinyi Tang,
Huaxi Xu,
and Shengjun Wang
|
| 425-425 |
A liquid fraction of extracellular matrix inhibits glioma cell viability in vitro and in vivo
A liquid fraction of extracellular matrix inhibits glioma cell viability in vitro and in vivo |
|
https://doi.org/10.18632/oncotarget.28203
Mark H. Murdock,
George S. Hussey,
Jordan T. Chang,
Ryan C. Hill,
David G. Nascari,
Aparna V. Rao,
Kirk C. Hansen,
Lesley M. Foley,
T. Kevin Hitchens,
Nduka M. Amankulor,
and Stephen F. Badylak
|
| 426-438 |
Impact of combining vitamin C with radiation therapy in human breast cancer: does it matter?
Impact of combining vitamin C with radiation therapy in human breast cancer: does it matter? |
|
https://doi.org/10.18632/oncotarget.28204
Somayeh Khazaei,
Linn Nilsson,
Gabriel Adrian,
Helga Tryggvadottir,
Elise Konradsson,
Signe Borgquist,
Karolin Isaksson,
Crister Ceberg,
and Helena Jernström
|
| 439-453 |
Defining the mechanisms underlying cyclin dependent kinase control of HIF-1α
Defining the mechanisms underlying cyclin dependent kinase control of HIF-1α |
|
https://doi.org/10.18632/oncotarget.28208
Noel A. Warfel
|
| 454-455 |
Adjuvant osimertinib treatment in patients with early stage NSCLC (IB-IIIA): pathological pathway adaptations
Adjuvant osimertinib treatment in patients with early stage NSCLC (IB-IIIA): pathological pathway adaptations |
|
https://doi.org/10.18632/oncotarget.28210
Antonio Marchetti,
Fiamma Buttitta,
and Emanuela D’Angelo
|
| 456-463 |
Sequencing of BRCA1/2-alterations using NGS-based technology: annotation as a challenge
Sequencing of BRCA1/2-alterations using NGS-based technology: annotation as a challenge |
|
https://doi.org/10.18632/oncotarget.28213
Silvana Ebner,
Ria Winkelmann,
Saskia Martin,
Jens Köllermann,
Peter J. Wild,
and Melanie Demes
|
| 464-475 |
An investigation on [5 fluorouracil and epigallocatechin-3-gallate] complex activity on HT-29 cell death and its stability in gastrointestinal fluid
An investigation on [5 fluorouracil and epigallocatechin-3-gallate] complex activity on HT-29 cell death and its stability in gastrointestinal fluid |
|
https://doi.org/10.18632/oncotarget.28207
Laura Moracci,
Francesca Sensi,
Andrea Biccari,
Sara Crotti,
Elisa Gaio,
Federico Benetti,
Pietro Traldi,
Salvatore Pucciarelli,
and Marco Agostini
|
| 476-489 |
Transplantation of autologous bone marrow pre-loaded ex vivo with oncolytic myxoma virus is efficacious against drug-resistant Vk*MYC mouse myeloma
Transplantation of autologous bone marrow pre-loaded ex vivo with oncolytic myxoma virus is efficacious against drug-resistant Vk*MYC mouse myeloma |
|
https://doi.org/10.18632/oncotarget.28205
Nancy Y. Villa,
Masmudur M. Rahman,
Joseph Mamola,
Meaghen E. Sharik,
Ana Lemos de Matos,
Jacquelyn Kilbourne,
Kenneth Lowe,
Juliane Daggett-Vondras,
Julia D'Isabella,
Elizabeth Goras,
Marta Chesi,
P. Leif Bergsagel,
and Grant McFadden
|
| 490-504 |
Correction: Human astrocytes secrete IL-6 to promote glioma migration and invasion through upregulation of cytomembrane MMP14
Correction: Human astrocytes secrete IL-6 to promote glioma migration and invasion through upregulation of cytomembrane MMP14 |
|
https://doi.org/10.18632/oncotarget.28211
Weiliang Chen,
Tongliang Xia,
Donghai Wang,
Bin Huang,
Peng Zhao,
Jian Wang,
Xun Qu,
and Xingang Li
|
| 505-506 |
Correction: Tumor-suppressive microRNA-218 inhibits tumor angiogenesis via targeting the mTOR component RICTOR in prostate cancer
Correction: Tumor-suppressive microRNA-218 inhibits tumor angiogenesis via targeting the mTOR component RICTOR in prostate cancer |
|
https://doi.org/10.18632/oncotarget.28206
Bing Guan,
Kaijie Wu,
Jin Zeng,
Shan Xu,
Lijun Mu,
Yang Gao,
Ke Wang,
Zhenkun Ma,
Juanhua Tian,
Qi Shi,
Peng Guo,
Xinyang Wang,
Dalin He,
and Yuefeng Du
|
| 507-507 |
Cytogenetic and molecular analyses of 291 gastrointestinal stromal tumors: site-specific cytogenetic evolution as evidence of pathogenetic heterogeneity
Cytogenetic and molecular analyses of 291 gastrointestinal stromal tumors: site-specific cytogenetic evolution as evidence of pathogenetic heterogeneity |
|
https://doi.org/10.18632/oncotarget.28209
Ludmila Gorunova,
Kjetil Boye,
Ioannis Panagopoulos,
Jeanne-Marie Berner,
Bodil Bjerkehagen,
Ivar Hompland,
Ingvild Lobmaier,
Toto Hølmebakk,
Tarjei S. Hveem,
Sverre Heim,
and Francesca Micci
|
| 508-517 |
Correction: Clinical significance and effect of AEG-1 on the proliferation, invasion, and migration of NSCLC: a study based on immunohistochemistry, TCGA, bioinformatics, in vitro and in vivo verification
Correction: Clinical significance and effect of AEG-1 on the proliferation, invasion, and migration of NSCLC: a study based on immunohistochemistry, TCGA, bioinformatics, in vitro and in vivo verification |
|
https://doi.org/10.18632/oncotarget.28212
Yu Zhang,
Zu-Yun Li,
Xin-Xi Hou,
Xiao Wang,
Yi-Huan Luo,
Yan-Ping Ying,
and Gang Chen
|
| 518-520 |
Correlation of nuclear pIGF-1R/IGF-1R and YAP/TAZ in a tissue microarray with outcomes in osteosarcoma patients
Correlation of nuclear pIGF-1R/IGF-1R and YAP/TAZ in a tissue microarray with outcomes in osteosarcoma patients |
|
https://doi.org/10.18632/oncotarget.28215
Eric R. Molina,
Letitia K. Chim,
Salah-Eddine Lamhamedi-Cherradi,
Sana Mohiuddin,
David McCall,
Branko Cuglievan,
Sandhya Krishnan,
Robert W. Porter,
Davis R. Ingram,
Wei-Lien Wang,
Alexander J. Lazar,
David W. Scott,
Danh D. Truong,
Najat C. Daw,
Joseph A. Ludwig,
and Antonios G. Mikos
|
| 521-533 |
MYH9 binds to dNTPs via deoxyribose moiety and plays an important role in DNA synthesis
MYH9 binds to dNTPs via deoxyribose moiety and plays an important role in DNA synthesis |
|
https://doi.org/10.18632/oncotarget.28219
Pratima Nangia-Makker,
Malathy P.V. Shekhar,
Victor Hogan,
Vitaly Balan,
and Avraham Raz
|
| 534-550 |
Retraction: Transcriptome analysis reveals a role for the endothelial ANP-GC-A signaling in interfering with pre-metastatic niche formation by solid cancers
Retraction: Transcriptome analysis reveals a role for the endothelial ANP-GC-A signaling in interfering with pre-metastatic niche formation by solid cancers |
|
https://doi.org/10.18632/oncotarget.28223
Takashi Nojiri,
Miki Arai,
Yutaka Suzuki,
Motofumi Kumazoe,
Takeshi Tokudome,
Koichi Miura,
Jun Hino,
Hiroshi Hosoda,
Mikiya Miyazato,
Meinoshin Okumura,
Shinpei Kawaoka,
and Kenji Kangawa
|
| 551-552 |
Patient-derived tumor models are attractive tools to repurpose drugs for ovarian cancer treatment: pre-clinical updates
Patient-derived tumor models are attractive tools to repurpose drugs for ovarian cancer treatment: pre-clinical updates |
|
https://doi.org/10.18632/oncotarget.28220
Magdalena Cybula,
and Magdalena Bieniasz
|
| 553-575 |
Resolution of radiation necrosis with bevacizumab following radiation therapy for primary CNS lymphoma
Resolution of radiation necrosis with bevacizumab following radiation therapy for primary CNS lymphoma |
|
https://doi.org/10.18632/oncotarget.28222
Eugene J. Vaios,
Kristen A. Batich,
Anne F. Buckley,
Anastasie Dunn-Pirio,
Mallika P. Patel,
John P. Kirkpatrick,
Ranjit Goudar,
and Katherine B. Peters
|
| 576-582 |
Correction: Silencing of CXCR4 sensitizes triple-negative breast cancer cells to cisplatin
Correction: Silencing of CXCR4 sensitizes triple-negative breast cancer cells to cisplatin |
|
https://doi.org/10.18632/oncotarget.28109
Sixian Liang,
Xun Peng,
Xiaoli Li,
Ping Yang,
Linhao Xie,
Yaochen Li,
Caiwen Du,
and Guojun Zhang
|
| 583-584 |
Correction: Lysosomal sequestration of hydrophobic weak base chemotherapeutics triggers lysosomal biogenesis and lysosome-dependent cancer multidrug resistance
Correction: Lysosomal sequestration of hydrophobic weak base chemotherapeutics triggers lysosomal biogenesis and lysosome-dependent cancer multidrug resistance |
|
https://doi.org/10.18632/oncotarget.28110
Benny Zhitomirsky,
and Yehuda G. Assaraf
|
| 585-586 |
Role of the prorenin receptor in endometrial cancer cell growth
Role of the prorenin receptor in endometrial cancer cell growth |
|
https://doi.org/10.18632/oncotarget.28224
Jacinta H. Martin,
Riazuddin Mohammed,
Sarah J. Delforce,
David A. Skerrett-Byrne,
Celine Corbisier de Meaultsart,
Juhura G. Almazi,
Andrew N. Stephens,
Nicole M. Verrills,
Evdokia Dimitriadis,
Yu Wang,
Eugenie R. Lumbers,
and Kirsty G. Pringle
|
| 587-599 |
A novel group of genes that cause endocrine resistance in breast cancer identified by dynamic gene expression analysis
A novel group of genes that cause endocrine resistance in breast cancer identified by dynamic gene expression analysis |
|
https://doi.org/10.18632/oncotarget.28225
Arvand Asghari,
Katherine Wall,
Michael Gill,
Natascha Del Vecchio,
Farnaz Allahbakhsh,
Jacky Wu,
Nan Deng,
W. Jim Zheng,
Hulin Wu,
Michihisa Umetani,
and Vahed Maroufy
|
| 600-613 |
Correction: MicroRNA-613 inhibits cell growth, migration and invasion of papillary thyroid carcinoma by regulating SphK2
Correction: MicroRNA-613 inhibits cell growth, migration and invasion of papillary thyroid carcinoma by regulating SphK2 |
|
https://doi.org/10.18632/oncotarget.28155
Wangwang Qiu,
Zhili Yang,
Youben Fan,
and Qi Zheng
|
| 614-614 |
Loss of DRO1/CCDC80 in the tumor microenvironment promotes carcinogenesis
Loss of DRO1/CCDC80 in the tumor microenvironment promotes carcinogenesis |
|
https://doi.org/10.18632/oncotarget.28084
Jessica I. Christian,
Agnieszka Pastula,
Andreas Herbst,
Jens Neumann,
Maximilian K. Marschall,
Andrea Ofner,
Heike Zierahn,
Marlon R. Schneider,
Eckhard Wolf,
Michael Quante,
and Frank T. Kolligs
|
| 615-627 |
Bladder cancer survival in patients with NOD2 or CDKN2A variants
Bladder cancer survival in patients with NOD2 or CDKN2A variants |
|
https://doi.org/10.18632/oncotarget.28226
Elżbieta Złowocka-Perłowska,
Thierry van de Wetering,
Aleksandra Tołoczko-Grabarek,
Rodney J. Scott,
and Jan Lubiński
|
| 628-640 |
Correction: MR imaging biomarkers evaluating vascular normalization window after anti-vessel treatment
Correction: MR imaging biomarkers evaluating vascular normalization window after anti-vessel treatment |
|
https://doi.org/10.18632/oncotarget.28217
Jun Yang,
Chengde Liao,
Yifan Liu,
Guangjun Yang,
Tengfei Ke,
Yingying Ding,
and Qinqing Li
|
| 641-641 |
Combined treatment with niclosamide and camptothecin enhances anticancer effect in U87 MG human glioblastoma cells
Combined treatment with niclosamide and camptothecin enhances anticancer effect in U87 MG human glioblastoma cells |
|
https://doi.org/10.18632/oncotarget.28227
Laura Valdez,
Benxu Cheng,
Daniela Gonzalez,
Reanna Rodriguez,
Paola Campano,
Andrew Tsin,
and Xiaoqian Fang
|
| 642-658 |
Proteomic analysis reveals dual requirement for Grb2 and PLCγ1 interactions for BCR-FGFR1-Driven 8p11 cell proliferation
Proteomic analysis reveals dual requirement for Grb2 and PLCγ1 interactions for BCR-FGFR1-Driven 8p11 cell proliferation |
|
https://doi.org/10.18632/oncotarget.28228
Malalage N. Peiris,
April N. Meyer,
Dalida Warda,
Alexandre Rosa Campos,
and Daniel J. Donoghue
|
| 659-676 |
Tazemetostat in relapsed/refractory follicular lymphoma: a propensity score–matched analysis of E7438-G000-101 trial outcomes
Tazemetostat in relapsed/refractory follicular lymphoma: a propensity score–matched analysis of E7438-G000-101 trial outcomes |
|
https://doi.org/10.18632/oncotarget.28229
David G. Proudman,
Deepshekhar Gupta,
Dave Nellesen,
Jay Yang,
Beth A. Kamp,
Khalid Mamlouk,
and Bruce D. Cheson
|
| 677-683 |
Correction: Silence of cancer susceptibility candidate 9 inhibits gastric cancer and reverses chemoresistance
Correction: Silence of cancer susceptibility candidate 9 inhibits gastric cancer and reverses chemoresistance |
|
https://doi.org/10.18632/oncotarget.27523
Chao Shang,
Lin Sun,
Jiale Zhang,
Bochao Zhao,
Xiuxiu Chen,
Huimian Xu,
and Baojun Huang
|
| 684-685 |
Response to immunotherapy in KRAS G12C mutated NSCLC: a single-centre retrospective observational study
Response to immunotherapy in KRAS G12C mutated NSCLC: a single-centre retrospective observational study |
|
https://doi.org/10.18632/oncotarget.28230
Carolina Sciortino,
Valentina Viglialoro,
Massimo Nucci,
Mariam Grazia Polito,
Enrico Cortesi,
Alain Gelibter,
Paola Gazzaniga,
Chiara Nicolazzo,
Marco Siringo,
and Salvatore Caponnetto
|
| 686-693 |
Correction: LncRNA AFAP1-AS1 promotes growth and metastasis of cholangiocarcinoma cells
Correction: LncRNA AFAP1-AS1 promotes growth and metastasis of cholangiocarcinoma cells |
|
https://doi.org/10.18632/oncotarget.28216
Xiuhui Shi,
Hang Zhang,
Min Wang,
Xiaodong Xu,
Yan Zhao,
Ruizhi He,
Min Zhang,
Min Zhou,
Xu Li,
Feng Peng,
Chengjian Shi,
Ming Shen,
Xin Wang,
Xingjun Guo,
and Renyi Qin
|
| 694 |
CancerOmicsNet: a multi-omics network-based approach to anti-cancer drug profiling
CancerOmicsNet: a multi-omics network-based approach to anti-cancer drug profiling |
|
https://doi.org/10.18632/oncotarget.28234
Limeng Pu,
Manali Singha,
Jagannathan Ramanujam,
and Michal Brylinski
|
| 695-706 |
NF-κB over-activation portends improved outcomes in HPV-associated head and neck cancer
NF-κB over-activation portends improved outcomes in HPV-associated head and neck cancer |
|
https://doi.org/10.18632/oncotarget.28232
Travis P. Schrank,
Andrew C. Prince,
Tejas Sathe,
Xiaowei Wang,
Xinyi Liu,
Damir T. Alzhanov,
Barbara Burtness,
Albert S. Baldwin,
Wendell G. Yarbrough,
and Natalia Issaeva
|
| 707-722 |
Correction: Mouse Sirt3 promotes autophagy in AngII-induced myocardial hypertrophy through the deacetylation of FoxO1
Correction: Mouse Sirt3 promotes autophagy in AngII-induced myocardial hypertrophy through the deacetylation of FoxO1 |
|
https://doi.org/10.18632/oncotarget.28146
Jingyuan Li,
Tongshuai Chen,
Ming Xiao,
Na Li,
Shujian Wang,
Hongyan Su,
Xiaobin Guo,
Hui Liu,
Fangying Yan,
Yi Yang,
Yun Zhang,
and Peili Bu
|
| 723-724 |
Deciphering miR-520c-3p as a probable target for immunometabolism in non-small cell lung cancer using systems biology approach
Deciphering miR-520c-3p as a probable target for immunometabolism in non-small cell lung cancer using systems biology approach |
|
https://doi.org/10.18632/oncotarget.28233
Pooja Gulhane,
Prajakta Nimsarkar,
Komal Kharat,
and Shailza Singh
|
| 725-746 |
HOXB9 mediates resistance to chemotherapy and patient outcomes through the TGFβ pathway in pancreatic cancer
HOXB9 mediates resistance to chemotherapy and patient outcomes through the TGFβ pathway in pancreatic cancer |
|
https://doi.org/10.18632/oncotarget.28235
Naokazu Chiba,
Shigeto Ochiai,
Takahiro Gunji,
Toshimichi Kobayashi,
Toru Sano,
Koichi Tomita,
and Shigeyuki Kawachi
|
| 747-754 |
Correction: Analysis of miRNA profiles identified miR-196a as a crucial mediator of aberrant PI3K/AKT signaling in lung cancer cells
Correction: Analysis of miRNA profiles identified miR-196a as a crucial mediator of aberrant PI3K/AKT signaling in lung cancer cells |
|
https://doi.org/10.18632/oncotarget.28237
Ilaria Guerriero,
Daniela D’Angelo,
Pierlorenzo Pallante,
Mafalda Santos,
Marianna Scrima,
Donatella Malanga,
Carmela De Marco,
Maria Ravo,
Alessandro Weisz,
Carmelo Laudanna,
Michele Ceccarelli,
Geppino Falco,
Antonia Rizzuto,
and Giuseppe Viglietto
|
| 755-755 |
Identification of lung cancer drivers by comparison of the observed and the expected numbers of missense and nonsense mutations in individual human genes
Identification of lung cancer drivers by comparison of the observed and the expected numbers of missense and nonsense mutations in individual human genes |
|
https://doi.org/10.18632/oncotarget.28231
Olga Y. Gorlova,
Marek Kimmel,
Spiridon Tsavachidis,
Christopher I. Amos,
and Ivan P. Gorlov
|
| 756-767 |
Targeting lipid metabolism in the treatment of ovarian cancer
Targeting lipid metabolism in the treatment of ovarian cancer |
|
https://doi.org/10.18632/oncotarget.28241
Saliha Chaudhry,
Stefani N. Thomas,
and Glenn E. Simmons Jr.
|
| 768-783 |
Correction: YAP promotes tumorigenesis and cisplatin resistance in neuroblastoma
Correction: YAP promotes tumorigenesis and cisplatin resistance in neuroblastoma |
|
https://doi.org/10.18632/oncotarget.28138
Chao Yang,
Juan Tan,
Jun Zhu,
Shan Wang,
and Guanghui Wei
|
| 784-784 |
IL-33 promotes gastric tumour growth in concert with activation and recruitment of inflammatory myeloid cells
IL-33 promotes gastric tumour growth in concert with activation and recruitment of inflammatory myeloid cells |
|
https://doi.org/10.18632/oncotarget.28238
Chau P. Tran,
Michelle Scurr,
Louise O’Connor,
Jon N. Buzzelli,
Garrett Z. Ng,
Sharleen Chung Nien Chin,
Lincon A. Stamp,
Toshinari Minamoto,
Andrew S. Giraud,
Louise M. Judd,
Philip Sutton,
and Trevelyan R. Menheniott
|
| 785-799 |
Are anaplastic lymphoma kinase (ALK) and O6-methylguanine-DNA methyltransferase (MGMT) promoter methylation driver biomarkers of pulmonary neuroendocrine tumors (NETs) and carcinomas (NECs)?
Are anaplastic lymphoma kinase (ALK) and O6-methylguanine-DNA methyltransferase (MGMT) promoter methylation driver biomarkers of pulmonary neuroendocrine tumors (NETs) and carcinomas (NECs)? |
|
https://doi.org/10.18632/oncotarget.28240
Birgitta Hiddinga,
Karen Zwaenepoel,
Annelies Janssens,
Jan Van Meerbeeck,
and Patrick Pauwels
|
| 800-809 |
Correction: Neferine inhibits proliferation and collagen synthesis induced by high glucose in cardiac fibroblasts and reduces cardiac fibrosis in diabetic mice
Correction: Neferine inhibits proliferation and collagen synthesis induced by high glucose in cardiac fibroblasts and reduces cardiac fibrosis in diabetic mice |
|
https://doi.org/10.18632/oncotarget.28214
Xue Liu,
Xiuhui Song,
Jianjun Lu,
Xueying Chen,
Ershun Liang,
Xiaoqiong Liu,
Mingxiang Zhang,
Yun Zhang,
Zhanhui Du,
and Yuxia Zhao
|
| 810-811 |
Alectinib after failure to crizotinib in patients with ALK-positive non-small cell lung cancer: results from the Spanish early access program
Alectinib after failure to crizotinib in patients with ALK-positive non-small cell lung cancer: results from the Spanish early access program |
|
https://doi.org/10.18632/oncotarget.28244
Reyes Bernabé-Caro,
Pilar Garrido,
Rosario García-Campelo,
Ramón Palmero,
Ángel Artal,
Cristina Bayona,
Delvys Rodríguez-Abreu,
Marta López-Brea,
Alfredo Paredes,
David Vicente,
José Miguel Sánchez Torres,
Margarita Majem,
Pilar Diz,
Rocío Gordo,
Margarita Coca,
and Javier de Castro
|
| 812-827 |
Early-onset pancreatic cancer: a review of molecular mechanisms, management, and survival
Early-onset pancreatic cancer: a review of molecular mechanisms, management, and survival |
|
https://doi.org/10.18632/oncotarget.28242
Mark B. Ulanja,
Alastair E. Moody,
Bryce D. Beutler,
Daniel Antwi-Amoabeng,
Ganiyu A. Rahman,
and Olatunji B. Alese
|
| 828-841 |
Retraction: MicroRNA-497 inhibits thyroid cancer tumor growth and invasion by suppressing BDNF
Retraction: MicroRNA-497 inhibits thyroid cancer tumor growth and invasion by suppressing BDNF |
|
https://doi.org/10.18632/oncotarget.28248
Peisong Wang,
Xianying Meng,
Yan Huang,
Zhi Lv,
Jia Liu,
Guimin Wang,
Wei Meng,
Shuai Xue,
Qiang Zhang,
Pengju Zhang,
and Guang Chen
|
| 842-842 |
Role of germline variants in the metastasis of breast carcinomas
Role of germline variants in the metastasis of breast carcinomas |
|
https://doi.org/10.18632/oncotarget.28250
Ángela Santonja,
Aurelio A. Moya-García,
Nuria Ribelles,
Begoña Jiménez-Rodríguez,
Bella Pajares,
Cristina E. Fernández-De Sousa,
Elísabeth Pérez-Ruiz,
María del Monte-Millán,
Manuel Ruiz-Borrego,
Juan de la Haba,
Pedro Sánchez-Rovira,
Atocha Romero,
Anna González-Neira,
Ana Lluch,
and Emilio Alba
|
| 843-862 |
Retraction: MicroRNA-218 inhibits proliferation and invasion in ovarian cancer by targeting Runx2
Retraction: MicroRNA-218 inhibits proliferation and invasion in ovarian cancer by targeting Runx2 |
|
https://doi.org/10.18632/oncotarget.28253
Na Li,
Lufei Wang,
Guangyun Tan,
Zhiheng Guo,
Lei Liu,
Ming Yang,
and Jin He
|
| 863-863 |
Continuous treatment with abemaciclib leads to sustained and efficient inhibition of breast cancer cell proliferation
Continuous treatment with abemaciclib leads to sustained and efficient inhibition of breast cancer cell proliferation |
|
https://doi.org/10.18632/oncotarget.28249
Raquel Torres-Guzmán,
Maria Patricia Ganado,
Cecilia Mur,
Carlos Marugan,
Carmen Baquero,
Yanzhu Yang,
Yi Zeng,
Huimin Bian,
Jian Du,
Alfonso de Dios,
Oscar Puig,
and María José Lallena
|
| 864-875 |
Predicting cancer immunotherapy response from gut microbiomes using machine learning models
Predicting cancer immunotherapy response from gut microbiomes using machine learning models |
|
https://doi.org/10.18632/oncotarget.28252
Hai Liang,
Jay-Hyun Jo,
Zhiwei Zhang,
Margaret A. MacGibeny,
Jungmin Han,
Diana M. Proctor,
Monica E. Taylor,
You Che,
Paul Juneau,
Andrea B. Apolo,
John A. McCulloch,
Diwakar Davar,
Hassane M. Zarour,
Amiran K. Dzutsev,
Isaac Brownell,
Giorgio Trinchieri,
James L. Gulley,
and Heidi H. Kong
|
| 876-889 |
CUDC907, a dual phosphoinositide-3 kinase/histone deacetylase inhibitor, promotes apoptosis of NF2 Schwannoma cells
CUDC907, a dual phosphoinositide-3 kinase/histone deacetylase inhibitor, promotes apoptosis of NF2 Schwannoma cells |
|
https://doi.org/10.18632/oncotarget.28254
Julianne Huegel,
Christine T. Dinh,
Maria Martinelli,
Olena Bracho,
Rosa Rosario,
Haley Hardin,
Michael Estivill,
Anthony Griswold,
Sakir Gultekin,
Xue-Zhong Liu,
and Cristina Fernandez-Valle
|
| 890-904 |
Correction: Immunotherapy of ovarian cancer with a monoclonal antibody specific for the extracellular domain of anti-Müllerian hormone receptor II
Correction: Immunotherapy of ovarian cancer with a monoclonal antibody specific for the extracellular domain of anti-Müllerian hormone receptor II |
|
https://doi.org/10.18632/oncotarget.28246
Suparna Mazumder,
Valerie Swank,
Anton A. Komar,
Justin M. Johnson,
and Vincent K. Tuohy
|
| 905-906 |
Chemoradiation-induced alteration of programmed death-ligand 1, CD8+ tumor-infiltrating lymphocytes and mucin expression in rectal cancer
Chemoradiation-induced alteration of programmed death-ligand 1, CD8+ tumor-infiltrating lymphocytes and mucin expression in rectal cancer |
|
https://doi.org/10.18632/oncotarget.28255
Marina Baretti,
Qingfeng Zhu,
Wei Fu,
Jeffrey Meyer,
Hao Wang,
Robert A. Anders,
and Nilofer S. Azad
|
| 907-917 |
Diverse geroprotectors differently affect a mechanism linking cellular aging to cellular quiescence in budding yeast
Diverse geroprotectors differently affect a mechanism linking cellular aging to cellular quiescence in budding yeast |
|
https://doi.org/10.18632/oncotarget.28256
Anna Leonov,
Rachel Feldman,
Amanda Piano,
Anthony Arlia-Ciommo,
Jennifer Anne Baratang Junio,
Emmanuel Orfanos,
Tala Tafakori,
Vicky Lutchman,
Karamat Mohammad,
Sarah Elsaser,
Sandra Orfali,
Harshvardhan Rajen,
and Vladimir I. Titorenko
|
| 918-943 |
A novel mechanism of regulation of the oncogenic transcription factor GLI3 by toll-like receptor signaling
A novel mechanism of regulation of the oncogenic transcription factor GLI3 by toll-like receptor signaling |
|
https://doi.org/10.18632/oncotarget.28261
Stephan J. Matissek,
Mona Karbalivand,
Weiguo Han,
Ava Boutilier,
Estefania Yzar-Garcia,
Laura L. Kehoe,
Devin Storm Gardner,
Adam Hage,
Krista Fleck,
Vicki Jeffers,
Ricardo Rajsbaum,
and Sherine F. Elsawa
|
| 944-959 |
Glypican-3 (GPC3) is associated with MCPyV-negative status and impaired outcome in Merkel cell carcinoma
Glypican-3 (GPC3) is associated with MCPyV-negative status and impaired outcome in Merkel cell carcinoma |
|
https://doi.org/10.18632/oncotarget.28260
Sujatha Muralidharan,
Thibault Kervarrec,
Glen J. Weiss,
and Mahtab Samimi
|
| 960-967 |
Correction: Next-generation multimodality of nutrigenomic cancer therapy: sulforaphane in combination with acetazolamide actively target bronchial carcinoid cancer in disabling the PI3K/Akt/mTOR survival pathway and inducing apoptosis
Correction: Next-generation multimodality of nutrigenomic cancer therapy: sulforaphane in combination with acetazolamide actively target bronchial carcinoid cancer in disabling the PI3K/Akt/mTOR survival pathway and inducing apoptosis |
|
https://doi.org/10.18632/oncotarget.28104
Reza Bayat Mokhtari,
Bessi Qorri,
Narges Baluch,
Angelo Sparaneo,
Federico Pio Fabrizio,
Lucia Anna Muscarella,
Albina Tyker,
Sushil Kumar,
Hai-Ling Margaret Cheng,
Myron R. Szewczuk,
Bikul Das,
and Herman Yeger
|
| 968-969 |
Kinase activity profiling in renal cell carcinoma, benign renal tissue and in response to four different tyrosine kinase inhibitors
Kinase activity profiling in renal cell carcinoma, benign renal tissue and in response to four different tyrosine kinase inhibitors |
|
https://doi.org/10.18632/oncotarget.28257
Andliena Tahiri,
Katarina Puco,
Faris Naji,
Vessela N. Kristensen,
Glenny Cecilie Alfsen,
Lorant Farkas,
Frode S. Nilsen,
Stig Müller,
Jan Oldenburg,
and Jürgen Geisler
|
| 970-981 |
Addendum: A case report of androgen receptor inhibitor therapy in recurrent high-grade serous ovarian cancer
Addendum: A case report of androgen receptor inhibitor therapy in recurrent high-grade serous ovarian cancer |
|
https://doi.org/10.18632/oncotarget.28262
Sewanti Limaye,
Prashant Kumar,
Ramya Pragya,
Janani Sambath,
Darshana Patil,
Ajay Srinivasan,
Sachin Apurva,
Navin Srivastava,
Sanket Patil,
Revati Patil,
Vineet Datta,
Dadasaheb Akolkar,
and Rajan Datar
|
| 982-982 |
Addendum: A case series of advanced renal cell carcinoma patients treated with neoadjuvant cabozantinib prior to cytoreductive nephrectomy within the phase 2 CABOPRE trial
Addendum: A case series of advanced renal cell carcinoma patients treated with neoadjuvant cabozantinib prior to cytoreductive nephrectomy within the phase 2 CABOPRE trial |
|
https://doi.org/10.18632/oncotarget.28263
Guillermo de Velasco,
Lucia Carril-Ajuria,
Felix Guerrero-Ramos,
Teresa Alonso-Gordoa,
Juan F. Rodríguez-Moreno,
Alberto Carretero,
Maricruz Martin-Soberon,
Federico de la Rosa-Kehrmann,
and Daniel Castellano
|
| 983-983 |
Addendum: Standardized diagnostic algorithm for spitzoid lesions aids clinical decision-making and management: a case series from a Swiss reference center
Addendum: Standardized diagnostic algorithm for spitzoid lesions aids clinical decision-making and management: a case series from a Swiss reference center |
|
https://doi.org/10.18632/oncotarget.28264
Marie-Luise Hilbers,
Regula Brändli,
Beda Mühleisen,
Sandra N. Freiberger,
Joanna Mangana,
and Reinhard Dummer
|
| 984-984 |
Addendum: Immunotherapy in Xeroderma Pigmentosum: a case of advanced cutaneous squamous cell carcinoma treated with cemiplimab and a literature review
Addendum: Immunotherapy in Xeroderma Pigmentosum: a case of advanced cutaneous squamous cell carcinoma treated with cemiplimab and a literature review |
|
https://doi.org/10.18632/oncotarget.28265
Marco Rubatto,
Martina Merli,
Gianluca Avallone,
Andrea Agostini,
Luca Mastorino,
Virginia Caliendo,
Amelia Barcellini,
Viviana Vitolo,
Francesca Valvo,
Maria Teresa Fierro,
Simone Ribero,
and Pietro Quaglino
|
| 985-985 |
Combined epigenetic and immunotherapy for blastic and classical mantle cell lymphoma
Combined epigenetic and immunotherapy for blastic and classical mantle cell lymphoma |
|
https://doi.org/10.18632/oncotarget.28258
Francis R. LeBlanc,
Zainul S. Hasanali,
August Stuart,
Sara Shimko,
Kamal Sharma,
Violetta V. Leshchenko,
Samir Parekh,
Haiqing Fu,
Ya Zhang,
Melvenia M. Martin,
Mark Kester,
Todd Fox,
Jiangang Liao,
Thomas P. Loughran,
Juanita Evans,
Jeffrey J. Pu,
Stephen E. Spurgeon,
Mirit I. Aladjem,
and Elliot M. Epner
|
| 986-1002 |
Retraction: MicroRNA-182 downregulates Wnt/β-catenin signaling, inhibits proliferation, and promotes apoptosis in human osteosarcoma cells by targeting HOXA9
Retraction: MicroRNA-182 downregulates Wnt/β-catenin signaling, inhibits proliferation, and promotes apoptosis in human osteosarcoma cells by targeting HOXA9 |
|
https://doi.org/10.18632/oncotarget.28269
Zi-Feng Zhang,
Yong-Jian Wang,
Shao-Hua Fan,
Shi-Xin Du,
Xue-Dong Li,
Dong-Mei Wu,
Jun Lu,
and Yuan-Lin Zheng
|
| 1003-1003 |
Targeted elastin-like polypeptide fusion protein for near-infrared imaging of human and canine urothelial carcinoma
Targeted elastin-like polypeptide fusion protein for near-infrared imaging of human and canine urothelial carcinoma |
|
https://doi.org/10.18632/oncotarget.28271
Aayush Aayush,
Saloni Darji,
Deepika Dhawan,
Alexander Enstrom,
Meaghan M. Broman,
Muhammad T. Idrees,
Hristos Kaimakliotis,
Timothy Ratliff,
Deborah Knapp,
and David Thompson
|
| 1004-1016 |
An ABC transporter as a potential target against SHH-Medulloblastoma: From Benchtop to Bedside
An ABC transporter as a potential target against SHH-Medulloblastoma: From Benchtop to Bedside |
|
https://doi.org/10.18632/oncotarget.28272
Jingwen Zhu,
Joseph N. Miller,
and John D. Schuetz
|
| 1017-1019 |
Prediction of recurrence free survival for esophageal cancer patients using a protein signature based risk model
Prediction of recurrence free survival for esophageal cancer patients using a protein signature based risk model |
|
https://doi.org/10.18632/oncotarget.10656
Raghibul Hasan,
Gunjan Srivastava,
Akram Alyass,
Rinu Sharma,
Anoop Saraya,
Tushar K. Chattopadhyay,
Siddartha DattaGupta,
Paul G. Walfish,
Shyam S. Chauhan,
and Ranju Ralhan
|
| 1020-1032 |
Retraction: MicroRNA-433 inhibits oral squamous cell carcinoma cells by targeting FAK
Retraction: MicroRNA-433 inhibits oral squamous cell carcinoma cells by targeting FAK |
|
https://doi.org/10.18632/oncotarget.28270
Yong-Jian Wang,
Zi-Feng Zhang,
Shao-Hua Fan,
Juan Zhuang,
Qun Shan,
Xin-Rui Han,
Xin Wen,
Meng-Qiu Li,
Bin Hu,
Chun-Hui Sun,
Bin Qiao,
Qian Tao,
Dong-Mei Wu,
Jun Lu,
and Yuan-Lin Zheng
|
| 1033-1033 |
Site of analysis matters - Ongoing complete response to Nivolumab in a patient with HIV/HPV related metastatic anal cancer and MLH1 mutation
Site of analysis matters - Ongoing complete response to Nivolumab in a patient with HIV/HPV related metastatic anal cancer and MLH1 mutation |
|
https://doi.org/10.18632/oncotarget.28274
Melanie Demes,
Ursula Pession,
Jan Jeroch,
Falko Schulze,
Katrin Eichler,
Daniel Martin,
Peter Wild,
and Oliver Waidmann
|
| 1034-1042 |
Influence of high altitude on the expression of HIF-1 and on the prognosis of Ecuadorian patients with gastric adenocarcinoma
Influence of high altitude on the expression of HIF-1 and on the prognosis of Ecuadorian patients with gastric adenocarcinoma |
|
https://doi.org/10.18632/oncotarget.28275
Edwin Cevallos Barrera,
Edson Zangiacomi Martinez,
Mariangela Ottoboni Brunaldi,
Eduardo Antonio Donadi,
Ajith Kumar Sankarankutty,
Rafael Kemp,
and José Sebastiao dos Santos
|
| 1043-1053 |
Targeting Krebs-cycle-deficient renal cell carcinoma with Poly ADP-ribose polymerase inhibitors and low-dose alkylating chemotherapy
Targeting Krebs-cycle-deficient renal cell carcinoma with Poly ADP-ribose polymerase inhibitors and low-dose alkylating chemotherapy |
|
https://doi.org/10.18632/oncotarget.28273
Daiki Ueno,
Juan C. Vasquez,
Amrita Sule,
Jiayu Liang,
Jinny van Doorn,
Ranjini Sundaram,
Sam Friedman,
Randy Caliliw,
Shinji Ohtake,
Xun Bao,
Jing Li,
Huihui Ye,
Karla Boyd,
Rong Rong Huang,
Jack Dodson,
Paul Boutros,
Ranjit S. Bindra,
and Brian Shuch
|
| 1054-1067 |
Correction: Exploratory comparisons between different anti-mitotics in clinically-used drug combination in triple negative breast cancer
Correction: Exploratory comparisons between different anti-mitotics in clinically-used drug combination in triple negative breast cancer |
|
https://doi.org/10.18632/oncotarget.28266
Bruna Cândido Guido,
Douglas Cardoso Brandão,
Ana Luisa Augusto Barbosa,
Monique Jacob Xavier Vianna,
Lucas Faro,
Luciana Machado Ramos,
Fabíola Nihi,
Márcio Botelho de Castro,
Brenno A.D. Neto,
José Raimundo Corrêa,
and Sônia Nair Báo
|
| 1068-1068 |
Genomic alterations predictive of poor clinical outcomes in pan-cancer
Genomic alterations predictive of poor clinical outcomes in pan-cancer |
|
https://doi.org/10.18632/oncotarget.28276
Crystal S. Seldon,
Karthik Meiyappan,
Hannah Hoffman,
Jimmy A. Guo,
Neha Goel,
William L. Hwang,
Paul L. Nguyen,
Brandon A. Mahal,
and Mohammed Alshalalfa
|
| 1069-1077 |
Complementary CRISPR genome-wide genetic screens in PARP10-knockout and overexpressing cells identify synthetic interactions for PARP10-mediated cellular survival
Complementary CRISPR genome-wide genetic screens in PARP10-knockout and overexpressing cells identify synthetic interactions for PARP10-mediated cellular survival |
|
https://doi.org/10.18632/oncotarget.28277
Jude B. Khatib,
Emily M. Schleicher,
Lindsey M. Jackson,
Ashna Dhoonmoon,
George-Lucian Moldovan,
and Claudia M. Nicolae
|
| 1078-1091 |
Correction: Influence of nutrition on stage-stratified survival in gastric cancer patients with postoperative complications
Correction: Influence of nutrition on stage-stratified survival in gastric cancer patients with postoperative complications |
|
https://doi.org/10.18632/oncotarget.28243
Noriyuki Hirahara,
Takeshi Matsubara,
Shunsuke Kaji,
Yuki Uchida,
Ryoji Hyakudomi,
Tetsu Yamamoto,
Kiyoe Takai,
Yohei Sasaki,
Koki Kawakami,
and Yoshitsugu Tajima
|
| 1092-1093 |
In vitro chemotherapy-associated muscle toxicity is attenuated with nutritional support, while treatment efficacy is retained
In vitro chemotherapy-associated muscle toxicity is attenuated with nutritional support, while treatment efficacy is retained |
|
https://doi.org/10.18632/oncotarget.28279
Liza A. Wijler,
Francina J. Dijk,
Hanil Quirindongo,
Danielle A.E. Raats,
Bram Dorresteijn,
Matthew J.W. Furber,
Anne M. May,
Onno Kranenburg,
and Miriam van Dijk
|
| 1094-1108 |
Effectiveness of radiotherapy for local control in T3N0 rectal cancer managed with total mesorectal excision: a meta-analysis
Effectiveness of radiotherapy for local control in T3N0 rectal cancer managed with total mesorectal excision: a meta-analysis |
|
https://doi.org/10.18632/oncotarget.28280
Michael Jonathan Kucharczyk,
Andrew Bang,
Michael C. Tjong,
Stefania Papatheodorou,
and Jesus C. Fabregas
|
| 1109-1119 |
Correction: Oncogenic RAS-induced senescence in human primary thyrocytes: molecular effectors and inflammatory secretome involved
Correction: Oncogenic RAS-induced senescence in human primary thyrocytes: molecular effectors and inflammatory secretome involved |
|
https://doi.org/10.18632/oncotarget.28027
Maria Grazia Vizioli,
Joana Santos,
Silvana Pilotti,
Mara Mazzoni,
Maria Chiara Anania,
Claudia Miranda,
Sonia Pagliardini,
Marco A. Pierotti,
Jesus Gil,
and Angela Greco
|
| 1120-1121 |
HDAC inhibitors suppress protein poly(ADP-ribosyl)ation and DNA repair protein levels and phosphorylation status in hematologic cancer cells: implications for their use in combination with PARP inhibitors and chemotherapeutic drugs
HDAC inhibitors suppress protein poly(ADP-ribosyl)ation and DNA repair protein levels and phosphorylation status in hematologic cancer cells: implications for their use in combination with PARP inhibitors and chemotherapeutic drugs |
|
https://doi.org/10.18632/oncotarget.28278
Benigno C. Valdez,
Yago Nieto,
Bin Yuan,
David Murray,
and Borje S. Andersson
|
| 1122-1135 |
FSP1, a novel KEAP1/NRF2 target gene regulating ferroptosis and radioresistance in lung cancers
FSP1, a novel KEAP1/NRF2 target gene regulating ferroptosis and radioresistance in lung cancers |
|
https://doi.org/10.18632/oncotarget.28301
Nsengiyumva Emmanuel,
Hongen Li,
Jing Chen,
and Yilei Zhang
|
| 1136-1139 |
Platelet-derived growth factor (PDGF) cross-signaling via non-corresponding receptors indicates bypassed signaling in colorectal cancer
Platelet-derived growth factor (PDGF) cross-signaling via non-corresponding receptors indicates bypassed signaling in colorectal cancer |
|
https://doi.org/10.18632/oncotarget.28281
Romana Moench,
Martin Gasser,
Karol Nawalaniec,
Tanja Grimmig,
Amrendra K. Ajay,
Larissa Camila Ribeiro de Souza,
Minghua Cao,
Yueming Luo,
Petra Hoegger,
Carmen M. Ribas,
Jurandir M. Ribas-Filho,
Osvaldo Malafaia,
Reinhard Lissner,
Li-Li Hsiao,
and Ana Maria Waaga-Gasser
|
| 1140-1152 |
Correction: Hyperthermia and associated changes in membrane fluidity potentiate P2X7 activation to promote tumor cell death
Correction: Hyperthermia and associated changes in membrane fluidity potentiate P2X7 activation to promote tumor cell death |
|
https://doi.org/10.18632/oncotarget.27641
Paola de Andrade Mello,
Shu Bian,
Luiz Eduardo Baggio Savio,
Haohai Zhang,
Jingping Zhang,
Wolfgang Junger,
Márcia Rosângela Wink,
Guido Lenz,
Andréia Buffon,
Yan Wu,
and Simon Christopher Robson
|
| 1153-1154 |
Therapeutic efficacy of the humanized JAA-F11 anti-Thomsen-Friedenreich antibody constructs H2aL2a and H3L3 in human breast and lung cancer xenograft models
Therapeutic efficacy of the humanized JAA-F11 anti-Thomsen-Friedenreich antibody constructs H2aL2a and H3L3 in human breast and lung cancer xenograft models |
|
https://doi.org/10.18632/oncotarget.28282
Diala Ghazal,
Fatma Zalzala,
John C. Fisk,
Swetha Tati,
Loukia G. Karacosta,
Susan Morey,
James R. Olson,
Sally Quataert,
Grace K. Dy,
and Kate Rittenhouse-Olson
|
| 1155-1164 |
Addendum: Resolution of radiation necrosis with bevacizumab following radiation therapy for primary CNS lymphoma
Addendum: Resolution of radiation necrosis with bevacizumab following radiation therapy for primary CNS lymphoma |
|
https://doi.org/10.18632/oncotarget.28292
Eugene J. Vaios,
Kristen A. Batich,
Anne F. Buckley,
Anastasie Dunn-Pirio,
Mallika P. Patel,
John P. Kirkpatrick,
Ranjit Goudar,
and Katherine B. Peters
|
| 1165-1165 |
Nectin-4 is widely expressed in head and neck squamous cell carcinoma
Nectin-4 is widely expressed in head and neck squamous cell carcinoma |
|
https://doi.org/10.18632/oncotarget.28299
Christine Sanders,
Jan-Frederic Lau,
Dimo Dietrich,
Sebastian Strieth,
Peter Brossart,
and Glen Kristiansen
|
| 1166-1173 |
Addendum: The value of comprehensive genomic sequencing to maximize the identification of clinically actionable alterations in advanced cancer patients: a case series
Addendum: The value of comprehensive genomic sequencing to maximize the identification of clinically actionable alterations in advanced cancer patients: a case series |
|
https://doi.org/10.18632/oncotarget.28294
Kevin Drenner,
Gargi D. Basu,
Laurie J. Goodman,
Audrey A. Ozols,
Janine R. LoBello,
Thomas Royce,
Michael S. Gordon,
Erkut H. Borazanci,
Margaux A. Steinbach,
Jeffrey Trent,
and Sunil Sharma
|
| 1174-1174 |
The serine protease matriptase inhibits migration and proliferation in multiple myeloma cells
The serine protease matriptase inhibits migration and proliferation in multiple myeloma cells |
|
https://doi.org/10.18632/oncotarget.28300
Ida Steiro,
Esten N. Vandsemb,
Samah Elsaadi,
Kristine Misund,
Anne-Marit Sponaas,
Magne Børset,
Pegah Abdollahi,
and Tobias S. Slørdahl
|
| 1175-1186 |
Correction: THBS2 as a prognostic biomarker for patients diagnosed with metastatic pancreatic ductal adenocarcinoma
Correction: THBS2 as a prognostic biomarker for patients diagnosed with metastatic pancreatic ductal adenocarcinoma |
|
https://doi.org/10.18632/oncotarget.28127
Phyllis A. Gimotty,
Jacob E. Till,
Shirsa Udgata,
Naomi Takenaka,
Stephanie S. Yee,
Michael J. LaRiviere,
Mark H. O’Hara,
Kim A. Reiss,
Peter O’Dwyer,
Bryson W. Katona,
Daniel Herman,
Erica L. Carpenter,
and Kenneth S. Zaret
|
| 1187-1187 |
Predictive molecular biomarkers for determining neoadjuvant chemosensitivity in muscle invasive bladder cancer
Predictive molecular biomarkers for determining neoadjuvant chemosensitivity in muscle invasive bladder cancer |
|
https://doi.org/10.18632/oncotarget.28302
Neal Murphy,
Andrew J. Shih,
Paras Shah,
Oksana Yaskiv,
Houman Khalili,
Anthony Liew,
Annette T. Lee,
and Xin-Hua Zhu
|
| 1188-1200 |
Retraction: SAMMSON drives the self-renewal of liver tumor initiating cells through EZH2-dependent Wnt/β-catenin activation
Retraction: SAMMSON drives the self-renewal of liver tumor initiating cells through EZH2-dependent Wnt/β-catenin activation |
|
https://doi.org/10.18632/oncotarget.28307
Xiaopeng Li,
Ming Li,
JiaLi Chen,
Hua Dai,
Liang Wang,
Ying Xiong,
Yuanbin Zhong,
and Lunli Zhang
|
| 1201-1201 |
Tumor hyaluronan as a novel biomarker in non-small cell lung cancer: A retrospective study
Tumor hyaluronan as a novel biomarker in non-small cell lung cancer: A retrospective study |
|
https://doi.org/10.18632/oncotarget.28304
Jun Gong,
Michelle Guan,
Haesoo Kim,
Natalie Moshayedi,
Sejal Mehta,
Galen Cook-Wiens,
Brent K. Larson,
Jenny Zhou,
Rishi Patel,
Isaac Lapite,
Veronica R. Placencio-Hickok,
Richard Tuli,
Ronald B. Natale,
and Andrew E. Hendifar
|
| 1202-1214 |
Addendum: Liquid biopsy and multi-analyte testing guided treatment of HER2 positive periampullary adenocarcinoma with durable complete response after trastuzumab based therapy
Addendum: Liquid biopsy and multi-analyte testing guided treatment of HER2 positive periampullary adenocarcinoma with durable complete response after trastuzumab based therapy |
|
https://doi.org/10.18632/oncotarget.28296
Rajnish Nagarkar,
Darshana Patil,
Sewanti Limaye,
Pradip Devhare,
Ashwini Ghaisas,
Navin Srivastava,
Sachin Apurwa,
Sanket Patil,
Jinumary John,
Zarrine Raazi,
Aditya Shreenivas,
Janani Sambath,
Ajay Srinivasan,
Prashant Kumar,
Dadasaheb Akolkar,
and Rajan Datar
|
| 1215-1215 |
Addendum: Polyclonal on- and off-target resistance mutations in an EML4-ALK positive non-small cell lung cancer patient under ALK inhibition
Addendum: Polyclonal on- and off-target resistance mutations in an EML4-ALK positive non-small cell lung cancer patient under ALK inhibition |
|
https://doi.org/10.18632/oncotarget.28293
Marcel Kemper,
Georg Evers,
Arik Bernard Schulze,
Jan Sperveslage,
Christoph Schülke,
Georg Lenz,
Thomas Herold,
Wolfgang Hartmann,
Hans-Ulrich Schildhaus,
and Annalen Bleckmann
|
| 1216-1216 |
MK256 is a novel CDK8 inhibitor with potent antitumor activity in AML through downregulation of the STAT pathway
MK256 is a novel CDK8 inhibitor with potent antitumor activity in AML through downregulation of the STAT pathway |
|
https://doi.org/10.18632/oncotarget.28305
Jen-Chieh Lee,
Shu Liu,
Yucheng Wang,
You Liang,
and David M. Jablons
|
| 1217-1236 |
Mutation analysis performed on tumor biopsies from patients with newly-diagnosed germinal center aggressive B cell lymphomas
Mutation analysis performed on tumor biopsies from patients with newly-diagnosed germinal center aggressive B cell lymphomas |
|
https://doi.org/10.18632/oncotarget.28309
Daniel J. Landsburg,
Jennifer J.D. Morrissette,
Stephen J. Schuster,
Sunita D. Nasta,
James N. Gerson,
Stefan K. Barta,
Jakub Svoboda,
Elise A. Chong,
and Megan S. Lim
|
| 1237-1244 |
Addendum: Hyperprogression to a dual immune blockade followed by subsequent response with cabozantinib in metastatic poor-risk clear cell renal cell carcinoma with NOTCH mutation
Addendum: Hyperprogression to a dual immune blockade followed by subsequent response with cabozantinib in metastatic poor-risk clear cell renal cell carcinoma with NOTCH mutation |
|
https://doi.org/10.18632/oncotarget.28312
Javier Molina-Cerrillo,
Teresa Alonso-Gordoa,
Alfredo Carrato,
and Enrique Grande
|
| 1245-1245 |
Treasures from trash in cancer research
Treasures from trash in cancer research |
|
https://doi.org/10.18632/oncotarget.28308
Fabiano Cordeiro Moreira,
Dionison Pereira Sarquis,
Jorge Estefano Santana de Souza,
Daniel de Souza Avelar,
Taíssa Maria Thomaz Araújo,
André Salim Khayat,
Sidney Emanuel Batista dos Santos,
and Paulo Pimentel de Assumpção
|
| 1246-1257 |
Retraction: Long non-coding RNA XIST promotes cell growth and metastasis through regulating miR-139-5p mediated Wnt/β-catenin signaling pathway in bladder cancer
Retraction: Long non-coding RNA XIST promotes cell growth and metastasis through regulating miR-139-5p mediated Wnt/β-catenin signaling pathway in bladder cancer |
|
https://doi.org/10.18632/oncotarget.28314
Yangyang Hu,
Chao Deng,
He Zhang,
Jing Zhang,
Bo Peng,
and Chuanyi Hu
|
| 1258-1258 |
Association of fall rate and functional status by APOE genotype in cancer survivors after exercise intervention
Association of fall rate and functional status by APOE genotype in cancer survivors after exercise intervention |
|
https://doi.org/10.18632/oncotarget.28310
Gwendolyn J. McGinnis,
Sarah Holden,
Betty Yu,
Charlton Ransom,
Carolyn Guidarelli,
Brian De,
Kevin Diao,
David Boyce,
Charles R. Thomas Jr.,
Kerri Winters-Stone,
and Jacob Raber
|
| 1259-1270 |
Addendum: Multiple primary lung cancer displaying different EGFR and PTEN molecular profiles
Addendum: Multiple primary lung cancer displaying different EGFR and PTEN molecular profiles |
|
https://doi.org/10.18632/oncotarget.28313
Zhouyu Zhu,
Tao Yu,
and Ying Chai
|
| 1271-1271 |
Correction: Evaluation of 6-mercaptopurine in a cell culture model of adaptable triple-negative breast cancer with metastatic potential
Correction: Evaluation of 6-mercaptopurine in a cell culture model of adaptable triple-negative breast cancer with metastatic potential |
|
https://doi.org/10.18632/oncotarget.28311
Balraj Singh,
Vanessa N. Sarli,
Hannah E. Kinne,
Anna Shamsnia,
and Anthony Lucci
|
| 1272-1272 |
Myeloid-derived suppressor cells: Cancer, autoimmune diseases, and more
Myeloid-derived suppressor cells: Cancer, autoimmune diseases, and more |
|
https://doi.org/10.18632/oncotarget.28303
Masahiko Shibata,
Kotaro Nanno,
Daigo Yoshimori,
Takahiro Nakajima,
Makoto Takada,
Takashi Yazawa,
Kousaku Mimura,
Norio Inoue,
Takafumi Watanabe,
Kazunoshin Tachibana,
Satoshi Muto,
Tomoyuki Momma,
Yoshiyuki Suzuki,
Koji Kono,
Shungo Endo,
and Seiichi Takenoshita
|
| 1273-1285 |
Essential amino acids as diagnostic biomarkers of hepatocellular carcinoma based on metabolic analysis
Essential amino acids as diagnostic biomarkers of hepatocellular carcinoma based on metabolic analysis |
|
https://doi.org/10.18632/oncotarget.28306
Yuji Morine,
Tohru Utsunomiya,
Hisami Yamanaka-Okumura,
Yu Saito,
Shinichiro Yamada,
Tetsuya Ikemoto,
Satoru Imura,
Shohei Kinoshita,
Akiyoshi Hirayama,
Yasuhito Tanaka,
and Mitsuo Shimada
|
| 1286-1298 |
Addendum: Mutually exclusive lymphangiogenesis or perineural infiltration in human skin squamous-cell carcinoma
Addendum: Mutually exclusive lymphangiogenesis or perineural infiltration in human skin squamous-cell carcinoma |
|
https://doi.org/10.18632/oncotarget.28319
Julien Schaller,
Hélène Maby-El Hajjami,
Sylvie Rusakiewicz,
Kalliopi Ioannidou,
Nathalie Piazzon,
Alexandra Miles,
Déla Golshayan,
Olivier Gaide,
Daniel Hohl,
Daniel E. Speiser,
and Karin Schaeuble
|
| 1299-1299 |
Addendum: Neoadjuvant nimotuzumab plus chemoradiotherapy compared to neoadjuvant chemoradiotherapy and neoadjuvant chemotherapy for locally advanced esophageal squamous cell carcinoma
Addendum: Neoadjuvant nimotuzumab plus chemoradiotherapy compared to neoadjuvant chemoradiotherapy and neoadjuvant chemotherapy for locally advanced esophageal squamous cell carcinoma |
|
https://doi.org/10.18632/oncotarget.28320
Yongshun Chen,
Xiaoyuan Wu,
Daxuan Hao,
Xinyu Cheng,
Lei Zhang,
Yougai Zhang,
Shaobo Ke,
Wei Shi,
and Chunyu He
|
| 1300-1300 |
Retraction: TUSC3 induces autophagy in human non-small cell lung cancer cells through Wnt/β-catenin signaling
Retraction: TUSC3 induces autophagy in human non-small cell lung cancer cells through Wnt/β-catenin signaling |
|
https://doi.org/10.18632/oncotarget.28315
Yun Peng,
Jun Cao,
Xiao-Yi Yao,
Jian-Xin Wang,
Mei-Zuo Zhong,
Ping-Ping Gan,
and Jian-Huang Li
|
| 1301-1301 |
Addendum: Unravelling actionable biology using transcriptomic data to integrate mitotic index and Ki-67 in the management of lung neuroendocrine tumors
Addendum: Unravelling actionable biology using transcriptomic data to integrate mitotic index and Ki-67 in the management of lung neuroendocrine tumors |
|
https://doi.org/10.18632/oncotarget.28321
Venkata S.K. Manem,
Olga Sazonova,
Andréanne Gagné,
Michèle Orain,
Babak Khoshkrood-Mansoori,
Nathalie Gaudreault,
Yohan Bossé,
and Philippe Joubert
|
| 1302-1302 |
The future of bioorthogonal-chemistry for targeting of exosomes in precision medicine
The future of bioorthogonal-chemistry for targeting of exosomes in precision medicine |
|
https://doi.org/10.18632/oncotarget.28323
Mujib Ullah
|
| 1303-1304 |
Addendum: Hyperprogression and impact of tumor growth kinetics after PD1/PDL1 inhibition in head and neck squamous cell carcinoma
Addendum: Hyperprogression and impact of tumor growth kinetics after PD1/PDL1 inhibition in head and neck squamous cell carcinoma |
|
https://doi.org/10.18632/oncotarget.28316
Andy Karabajakian,
Thibaut Garrivier,
Carole Crozes,
Nicolas Gadot,
Jean-Yves Blay,
Frédéric Bérard,
Philippe Céruse,
Philippe Zrounba,
Pierre Saintigny,
Charles Mastier,
and Jérôme Fayette
|
| 1305-1305 |
Addendum: Real-world survival analysis by tumor mutational burden in non-small cell lung cancer: a multisite U.S. study
Addendum: Real-world survival analysis by tumor mutational burden in non-small cell lung cancer: a multisite U.S. study |
|
https://doi.org/10.18632/oncotarget.28318
Connor Willis,
Hillevi Bauer,
Trang H. Au,
Jyothi Menon,
Sudhir Unni,
Dao Tran,
Zachary Rivers,
Wallace Akerley,
Matthew B. Schabath,
Firas Badin,
Ashley Sekhon,
Malini Patel,
Bing Xia,
Beth Gustafson,
John L. Villano,
John-Michael Thomas,
Solomon J. Lubinga,
Michael A. Cantrell,
Diana Brixner,
and David Stenehjem
|
| 1306-1306 |
Addendum: Impact of BMI on the outcome of metastatic breast cancer patients treated with everolimus: a retrospective exploratory analysis of the BALLET study
Addendum: Impact of BMI on the outcome of metastatic breast cancer patients treated with everolimus: a retrospective exploratory analysis of the BALLET study |
|
https://doi.org/10.18632/oncotarget.28317
Silvia P. Corona,
Fabiola Giudici,
Guy Jerusalem,
Eva Ciruelos,
Carla Strina,
Marianna Sirico,
Ottavia Bernocchi,
Manuela Milani,
Martina Dester,
Nicoletta Ziglioli,
Giuseppina Barbieri,
Valeria Cervoni,
Filippo Montemurro,
and Daniele Generali
|
| 1307-1307 |
Expression of p-STAT3 and c-Myc correlates with P2-HNF4α expression in nonalcoholic fatty liver disease (NAFLD)
Expression of p-STAT3 and c-Myc correlates with P2-HNF4α expression in nonalcoholic fatty liver disease (NAFLD) |
|
https://doi.org/10.18632/oncotarget.28324
Mamoun Younes,
Lin Zhang,
Baharan Fekry,
and Kristin Eckel-Mahan
|
| 1308-1313 |
Plasma growth hormone is a potential biomarker of response to atezolizumab and bevacizumab in advanced hepatocellular carcinoma patients
Plasma growth hormone is a potential biomarker of response to atezolizumab and bevacizumab in advanced hepatocellular carcinoma patients |
|
https://doi.org/10.18632/oncotarget.28322
Yehia I. Mohamed,
Dan G. Duda,
Muhammad O. Awiwi,
Sunyoung S. Lee,
Lina Altameemi,
Lianchun Xiao,
Jeffrey S. Morris,
Robert A. Wolff,
Khaled M. Elsayes,
Rikita I. Hatia,
Aliya Qayyum,
Shadi M. Chamseddine,
Asif Rashid,
James C. Yao,
Armeen Mahvash,
Manal M. Hassan,
Hesham M. Amin,
and Ahmed Omar Kaseb
|
| 1314-1321 |
Retraction: Colon cancer-induced interleukin-35 inhibits beta-catenin-mediated pro-oncogenic activity
Retraction: Colon cancer-induced interleukin-35 inhibits beta-catenin-mediated pro-oncogenic activity |
|
https://doi.org/10.18632/oncotarget.28325
Yueqiang Jiang,
Yanling Ma,
RuiChao Li,
and JianHai Sun
|
| 1322-1322 |
The role of pyrethroid derivatives in autophagy and apoptosis crosstalk signaling and potential risk for malignancies
The role of pyrethroid derivatives in autophagy and apoptosis crosstalk signaling and potential risk for malignancies |
|
https://doi.org/10.18632/oncotarget.28328
Jyothi Puvula,
Narendra Maddu,
Nagajothi Gutam,
Asha Parimal,
and Pongali B. Raghavendra
|
| 1323-1340 |
Serum microRNAs as new criteria for referral to early palliative care services in treatment-naïve advanced cancer patients
Serum microRNAs as new criteria for referral to early palliative care services in treatment-naïve advanced cancer patients |
|
https://doi.org/10.18632/oncotarget.28327
Tomofumi Miura,
Shuichi Mitsunaga,
Juntaro Matsuzaki,
Satoko Takizawa,
Ken Kato,
Atsushi Ochiai,
and Takahiro Ochiya
|
| 1341-1349 |
Resistance of MMTV-NeuT/ATTAC mice to anti-PD-1 immune checkpoint therapy is associated with macrophage infiltration and Wnt pathway expression
Resistance of MMTV-NeuT/ATTAC mice to anti-PD-1 immune checkpoint therapy is associated with macrophage infiltration and Wnt pathway expression |
|
https://doi.org/10.18632/oncotarget.28330
Hongyan Yuan,
Lu Jin,
Handan Xiang,
Anannya Bhattacharya,
Philip E. Brandish,
Gretchen Baltus,
Alexander Tong,
Changyan Zhou,
and Robert I. Glazer
|
| 1350-1358 |
Anti-tumor effect of antibody drug conjugate ASP1235 targeting Fms-like tyrosine kinase 3 with venetoclax plus azacitidine in an acute myeloid leukemia xenograft mouse model
Anti-tumor effect of antibody drug conjugate ASP1235 targeting Fms-like tyrosine kinase 3 with venetoclax plus azacitidine in an acute myeloid leukemia xenograft mouse model |
|
https://doi.org/10.18632/oncotarget.28331
Hirofumi Tsuzuki,
Tatsuya Kawase,
Taisuke Nakazawa,
Masamichi Mori,
and Taku Yoshida
|
| 1359-1368 |
Correction: Efficacy of continuous EGFR-inhibition and role of Hedgehog in EGFR acquired resistance in human lung cancer cells with activating mutation of EGFR
Correction: Efficacy of continuous EGFR-inhibition and role of Hedgehog in EGFR acquired resistance in human lung cancer cells with activating mutation of EGFR |
|
https://doi.org/10.18632/oncotarget.28335
Carminia Maria Della Corte,
Umberto Malapelle,
Elena Vigliar,
Francesco Pepe,
Giancarlo Troncone,
Vincenza Ciaramella,
Teresa Troiani,
Erika Martinelli,
Valentina Belli,
Fortunato Ciardiello,
and Floriana Morgillo
|
| 1369-1369 |
Impact of Covid-19 on the management of patients with metastatic melanoma
Impact of Covid-19 on the management of patients with metastatic melanoma |
|
https://doi.org/10.18632/oncotarget.28333
Michèle Welti,
Phil F. Cheng,
Joanna Mangana,
Mitchell P. Levesque,
Reinhard Dummer,
and Laurence Imhof
|
| 1370-1379 |
Calcium signaling induced by 15-deoxy-prostamide-J2 promotes cell death by activating PERK, IP3R, and the mitochondrial permeability transition pore
Calcium signaling induced by 15-deoxy-prostamide-J2 promotes cell death by activating PERK, IP3R, and the mitochondrial permeability transition pore |
|
https://doi.org/10.18632/oncotarget.28334
Daniel A. Ladin,
Margaret M. Nelson,
Estefani Cota,
Catherine Colonna,
Colin Burns,
Jacques Robidoux,
Kelsey H. Fisher-Wellman,
and Rukiyah Van Dross-Anderson
|
| 1380-1396 |
